Dr. Muhammad Idrees, MD

Dr. Idrees practices at Adventist Health Bakersfield in Bakersfield, California, part of Adventist Health.

Dr. Idrees' NPI, 1720430127, was assigned on July 8, 2016. Dr. Idrees holds California license A166760.

Dr. Idrees' primary practice is Adventist Health Bakersfield, at 2615 Chester Avenue, Bakersfield, CA 93301 in Kern County. The practice phone is (661) 395-3000.

Dr. Idrees' primary practice is Adventist Health Bakersfield in Bakersfield, California, part of Adventist Health. Dr. Idrees is also affiliated with UW Medical Center - Montlake. The medical group on file is Vituity. Dmand AI also links Dr. Idrees to 1 more hospital and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Idrees practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Idrees' primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Idrees' licenses on file in 2 states: California and Washington.

CMS data shows 51 Medicare services from Dr. Idrees across 2 procedure codes in 2024, for 53 Medicare patients. Medicare paid $5,539 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 53 Medicare patients who saw Dr. Idrees in 2024. The largest group is 65 to 74, with 28 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 57% are also on Medicaid. Their average risk score is 3.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Idrees' median patient age at 64, with 49% women.

In 2024, Dr. Idrees wrote 24 Medicare Part D claims for 11 patients. 88% of them were for generic drugs. They cover 4 drugs, with $677 in total drug cost. In 2022, CMS named 157 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Idrees for performance year 2024, reported through an alternative payment model (APM). Dr. Idrees accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 118 papers to Dr. Idrees, published from 2011 to 2025. 2024 was the busiest year, with 11. The most frequent topics are Testicular Neoplasms, Biomarkers, Tumor and Immunohistochemistry. Dr. Idrees has published most often in Histopathology. Dr. Idrees' most frequent co-authors are Sean Williamson, Khaleel Ibrahim Al-Obaidy, MD and William John Anderson, BSC, MBCHB.

CMS Open Payments shows 72 general payments to Dr. Idrees from 10 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. Supernus Pharmaceuticals, Inc. paid the most, $527.